Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.440
+0.170 (7.49%)
At close: Oct 15, 2026, 4:00 PM EDT
2.470
+0.030 (1.23%)
Pre-market: Oct 16, 2026, 4:08 AM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $374.74 million as of October 15, 2026. It is the 16,751st most valuable company in the world and the 2,973rd biggest in the United States. Its market cap has increased by 16.09% in one year.
Market Cap
374.74M
Enterprise Value
178.60M
1-Year Change
16.09%
Global Rank
Country Rank
#2,973 United States
Category
ChartMarket Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $374.74M, a decrease of -42.32%. That is a compound annual growth rate of -5.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 374.74M | 87.27% |
| Dec 31, 2025 | 200.10M | 90.94% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
| Feb 3, 2016 | 649.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 427.54M |
| Capricor Therapeutics | 426.74M |
| Prothena Corporation | 421.48M |
| ARS Pharmaceuticals | 403.26M |
| Atea Pharmaceuticals | 402.63M |
| Galectin Therapeutics | 386.25M |
| vTv Therapeutics | 381.94M |
| Prelude Therapeutics | 381.08M |